Fragile X syndrome and an isodicentric X chromosome in a woman with multiple anomalies, developmental delay, and normal pubertal development

Debra L. Freedenberg, Louise W. Gane, Carolyn (Sue) Richards, Megan Lampe, Jennifer Hills, Rebecca O'Connor, David Manchester, Annette Taylor, Flora Tassone, Dennis Hulseberg, Randi J. Hagerman, Shivanand R. Patil

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We report on an individual with developmental delays, short stature, skeletal abnormalities, normal pubertal development, expansion of the fragile X triplet repeat, as well as an isodicentric X chromosome. S is a 19-year- old woman who presented for evaluation of developmental delay. Pregnancy was complicated by a threatened miscarriage. She was a healthy child with intellectual impairment noted in infancy. Although she had global delays, speech was noted to be disproportionately delayed with few words until age 3.5 years. Facial appearance was consistent with fragile X syndrome. Age of onset of menses was 11 years with normal breast development. A maternal male second cousin had been identified with fragile X syndrome based on DNA studies. The mother of this child (S's maternal first cousin) and the grandfather (S's maternal uncle) were both intellectually normal but were identified as carrying triplet expansions in the premutation range. S's mother had some school difficulties but was not identified as having global delays. Molecular analysis of S's fragile X alleles noted an expansion of more than 400 CGG repeats in one allele. Routine cytogenetic studies of peripheral blood noted the presence of an isodicentric X in 81 of 86 cells scored. Five of 86 cells were noted to be 45,X. Cytogenetic fra(X) studies from peripheral blood showed that the structurally normal chromosome had the fragile site in approximately 16% of the cells. Analysis of maternal fragile X alleles identified an allele with an expansion to ~110 repeats. FMRP studies detected the expression of the protein in 24% of cells studied. To our knowledge, this is the first patient reported with an isodicentric X and fragile X syndrome. Whereas her clinical phenotype is suggestive of fragile X syndrome, her skeletal abnormalities may represent the presence of the isodicentric X. Treatment of S with 20 mg/day of Prozac improved her behavior. In the climate of cost control, this individual reinforces the recommendation of obtaining chromosomes on individuals with developmental delay even with a family history of fragile X syndrome.

Original languageEnglish (US)
Pages (from-to)197-201
Number of pages5
JournalAmerican Journal of Medical Genetics
Volume85
Issue number3
DOIs
StatePublished - 1999
Externally publishedYes

Fingerprint

Fragile X Syndrome
X Chromosome
Mothers
Alleles
Cytogenetics
Chromosome Fragile Sites
Air Conditioning
Language Development Disorders
Trinucleotide Repeats
Menstruation
Cost Control
Fluoxetine
Spontaneous Abortion
Age of Onset
Breast
Chromosomes
Phenotype
Pregnancy
DNA
Proteins

Keywords

  • Fragile X syndrome
  • Isodicentric X
  • Turner phenotype

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Fragile X syndrome and an isodicentric X chromosome in a woman with multiple anomalies, developmental delay, and normal pubertal development. / Freedenberg, Debra L.; Gane, Louise W.; Richards, Carolyn (Sue); Lampe, Megan; Hills, Jennifer; O'Connor, Rebecca; Manchester, David; Taylor, Annette; Tassone, Flora; Hulseberg, Dennis; Hagerman, Randi J.; Patil, Shivanand R.

In: American Journal of Medical Genetics, Vol. 85, No. 3, 1999, p. 197-201.

Research output: Contribution to journalArticle

Freedenberg, Debra L. ; Gane, Louise W. ; Richards, Carolyn (Sue) ; Lampe, Megan ; Hills, Jennifer ; O'Connor, Rebecca ; Manchester, David ; Taylor, Annette ; Tassone, Flora ; Hulseberg, Dennis ; Hagerman, Randi J. ; Patil, Shivanand R. / Fragile X syndrome and an isodicentric X chromosome in a woman with multiple anomalies, developmental delay, and normal pubertal development. In: American Journal of Medical Genetics. 1999 ; Vol. 85, No. 3. pp. 197-201.
@article{708285ba0691459989f0437755c08481,
title = "Fragile X syndrome and an isodicentric X chromosome in a woman with multiple anomalies, developmental delay, and normal pubertal development",
abstract = "We report on an individual with developmental delays, short stature, skeletal abnormalities, normal pubertal development, expansion of the fragile X triplet repeat, as well as an isodicentric X chromosome. S is a 19-year- old woman who presented for evaluation of developmental delay. Pregnancy was complicated by a threatened miscarriage. She was a healthy child with intellectual impairment noted in infancy. Although she had global delays, speech was noted to be disproportionately delayed with few words until age 3.5 years. Facial appearance was consistent with fragile X syndrome. Age of onset of menses was 11 years with normal breast development. A maternal male second cousin had been identified with fragile X syndrome based on DNA studies. The mother of this child (S's maternal first cousin) and the grandfather (S's maternal uncle) were both intellectually normal but were identified as carrying triplet expansions in the premutation range. S's mother had some school difficulties but was not identified as having global delays. Molecular analysis of S's fragile X alleles noted an expansion of more than 400 CGG repeats in one allele. Routine cytogenetic studies of peripheral blood noted the presence of an isodicentric X in 81 of 86 cells scored. Five of 86 cells were noted to be 45,X. Cytogenetic fra(X) studies from peripheral blood showed that the structurally normal chromosome had the fragile site in approximately 16{\%} of the cells. Analysis of maternal fragile X alleles identified an allele with an expansion to ~110 repeats. FMRP studies detected the expression of the protein in 24{\%} of cells studied. To our knowledge, this is the first patient reported with an isodicentric X and fragile X syndrome. Whereas her clinical phenotype is suggestive of fragile X syndrome, her skeletal abnormalities may represent the presence of the isodicentric X. Treatment of S with 20 mg/day of Prozac improved her behavior. In the climate of cost control, this individual reinforces the recommendation of obtaining chromosomes on individuals with developmental delay even with a family history of fragile X syndrome.",
keywords = "Fragile X syndrome, Isodicentric X, Turner phenotype",
author = "Freedenberg, {Debra L.} and Gane, {Louise W.} and Richards, {Carolyn (Sue)} and Megan Lampe and Jennifer Hills and Rebecca O'Connor and David Manchester and Annette Taylor and Flora Tassone and Dennis Hulseberg and Hagerman, {Randi J.} and Patil, {Shivanand R.}",
year = "1999",
doi = "10.1002/(SICI)1096-8628(19990730)85:3<197::AID-AJMG1>3.0.CO;2-O",
language = "English (US)",
volume = "85",
pages = "197--201",
journal = "American Journal of Medical Genetics, Part A",
issn = "1552-4825",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Fragile X syndrome and an isodicentric X chromosome in a woman with multiple anomalies, developmental delay, and normal pubertal development

AU - Freedenberg, Debra L.

AU - Gane, Louise W.

AU - Richards, Carolyn (Sue)

AU - Lampe, Megan

AU - Hills, Jennifer

AU - O'Connor, Rebecca

AU - Manchester, David

AU - Taylor, Annette

AU - Tassone, Flora

AU - Hulseberg, Dennis

AU - Hagerman, Randi J.

AU - Patil, Shivanand R.

PY - 1999

Y1 - 1999

N2 - We report on an individual with developmental delays, short stature, skeletal abnormalities, normal pubertal development, expansion of the fragile X triplet repeat, as well as an isodicentric X chromosome. S is a 19-year- old woman who presented for evaluation of developmental delay. Pregnancy was complicated by a threatened miscarriage. She was a healthy child with intellectual impairment noted in infancy. Although she had global delays, speech was noted to be disproportionately delayed with few words until age 3.5 years. Facial appearance was consistent with fragile X syndrome. Age of onset of menses was 11 years with normal breast development. A maternal male second cousin had been identified with fragile X syndrome based on DNA studies. The mother of this child (S's maternal first cousin) and the grandfather (S's maternal uncle) were both intellectually normal but were identified as carrying triplet expansions in the premutation range. S's mother had some school difficulties but was not identified as having global delays. Molecular analysis of S's fragile X alleles noted an expansion of more than 400 CGG repeats in one allele. Routine cytogenetic studies of peripheral blood noted the presence of an isodicentric X in 81 of 86 cells scored. Five of 86 cells were noted to be 45,X. Cytogenetic fra(X) studies from peripheral blood showed that the structurally normal chromosome had the fragile site in approximately 16% of the cells. Analysis of maternal fragile X alleles identified an allele with an expansion to ~110 repeats. FMRP studies detected the expression of the protein in 24% of cells studied. To our knowledge, this is the first patient reported with an isodicentric X and fragile X syndrome. Whereas her clinical phenotype is suggestive of fragile X syndrome, her skeletal abnormalities may represent the presence of the isodicentric X. Treatment of S with 20 mg/day of Prozac improved her behavior. In the climate of cost control, this individual reinforces the recommendation of obtaining chromosomes on individuals with developmental delay even with a family history of fragile X syndrome.

AB - We report on an individual with developmental delays, short stature, skeletal abnormalities, normal pubertal development, expansion of the fragile X triplet repeat, as well as an isodicentric X chromosome. S is a 19-year- old woman who presented for evaluation of developmental delay. Pregnancy was complicated by a threatened miscarriage. She was a healthy child with intellectual impairment noted in infancy. Although she had global delays, speech was noted to be disproportionately delayed with few words until age 3.5 years. Facial appearance was consistent with fragile X syndrome. Age of onset of menses was 11 years with normal breast development. A maternal male second cousin had been identified with fragile X syndrome based on DNA studies. The mother of this child (S's maternal first cousin) and the grandfather (S's maternal uncle) were both intellectually normal but were identified as carrying triplet expansions in the premutation range. S's mother had some school difficulties but was not identified as having global delays. Molecular analysis of S's fragile X alleles noted an expansion of more than 400 CGG repeats in one allele. Routine cytogenetic studies of peripheral blood noted the presence of an isodicentric X in 81 of 86 cells scored. Five of 86 cells were noted to be 45,X. Cytogenetic fra(X) studies from peripheral blood showed that the structurally normal chromosome had the fragile site in approximately 16% of the cells. Analysis of maternal fragile X alleles identified an allele with an expansion to ~110 repeats. FMRP studies detected the expression of the protein in 24% of cells studied. To our knowledge, this is the first patient reported with an isodicentric X and fragile X syndrome. Whereas her clinical phenotype is suggestive of fragile X syndrome, her skeletal abnormalities may represent the presence of the isodicentric X. Treatment of S with 20 mg/day of Prozac improved her behavior. In the climate of cost control, this individual reinforces the recommendation of obtaining chromosomes on individuals with developmental delay even with a family history of fragile X syndrome.

KW - Fragile X syndrome

KW - Isodicentric X

KW - Turner phenotype

UR - http://www.scopus.com/inward/record.url?scp=0032993950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032993950&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1096-8628(19990730)85:3<197::AID-AJMG1>3.0.CO;2-O

DO - 10.1002/(SICI)1096-8628(19990730)85:3<197::AID-AJMG1>3.0.CO;2-O

M3 - Article

C2 - 10398226

AN - SCOPUS:0032993950

VL - 85

SP - 197

EP - 201

JO - American Journal of Medical Genetics, Part A

JF - American Journal of Medical Genetics, Part A

SN - 1552-4825

IS - 3

ER -